Drug shortage
Sodium Chloride 23.4% Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Current · updated Apr 1, 2025
Key facts
| Generic name | Sodium Chloride 23.4% Injection |
|---|---|
| Proprietary name | Sodium Chloride 23.4% |
| Company | Fresenius Kabi USA, LLC |
| Presentation | Sodium Chloride 23.4%, Injection, 4 meq/1 mL (NDC 63323-093-30) |
| Dosage form | Injection |
| Strength | 4 meq/1 mL |
| Status | Current |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Pediatric Total Parenteral Nutrition |
| Package NDCs | 63323-093-30 |
| First posted | Sep 18, 2023 |
| Last updated | Apr 1, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: